期刊
NATURE REVIEWS CLINICAL ONCOLOGY
卷 15, 期 10, 页码 593-594出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/s41571-018-0070-7
关键词
-
类别
Platinum-based chemotherapy has long been the mainstay first-line therapy for patients with non-small-cell lung cancer without a targetable driver mutation, but has limited effectiveness. Immunotherapy is drastically changing the treatment landscape for this group and improving survival outcomes, with focus turning to frontline immunotherapy combinations.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据